Clinical trials
Observational Inflammatory Bowel Diseases trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
137 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 3 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 8 |
| 2015 | 4 |
| 2016 | 4 |
| 2017 | 9 |
| 2018 | 10 |
| 2019 | 16 |
| 2020 | 16 |
| 2021 | 19 |
| 2022 | 15 |
| 2023 | 16 |
| 2024 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 137 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assiut University | 20 |
| Cedars-Sinai Medical Center | 3 |
| Chinese University of Hong Kong | 3 |
| Corporacion Parc Tauli | 3 |
| Shandong University | 3 |
| University of Aarhus | 3 |
| Central Hospital, Nancy, France | 2 |
| Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2 |
| IRCCS San Raffaele | 2 |
| Nanfang Hospital, Southern Medical University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Inflammatory Bowel Diseases | 137 |
| Crohn Disease | 33 |
| Colitis, Ulcerative | 30 |
| Irritable Bowel Syndrome | 9 |
| Colorectal Neoplasms | 7 |
| Arthritis, Rheumatoid | 4 |
| Arthritis, Psoriatic | 3 |
| Colonic Neoplasms | 3 |
| Anxiety Disorders | 2 |
| Asthma | 2 |
Trials
Showing 1 to 25 of 137. Each trial links to its page on Pharma Observatory.
37 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.